Fig. 2
From: LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
Correlations between WEE2-AS1 and clinical features of glioma
(A)–(E) The relationship between the WEE2-AS1 expression and the WHO grade (A), histological type (Astro, Astrocytoma; Oligo, Oligodendroglioma; Oligoastro, Oligoastrocytoma; GBM, Glioblastoma) (B), isocitrate dehydrogenase (IDH) status (C), 1p/19q codeletion status (D), and epidermal growth factor receptor (EGFR) status (E) of glioma by using the data of TCGA (Wilcoxon rank sum test, p < 0.001). (F) Receiver operating characteristic (ROC) analysis of WEE2-AS1 expression shows a high ability to discriminate glioma tissues from normal samples using the data of GTEx and TCGA. Data are represented as median ± upper and lower interquartile range. ****p < 0.0001